Inosine pranobex was associated with a reduction in mortality in COVID-19 by over 22%, as reported in a retrospective study utilizing complete health data from the Czech national registry

Inosine pranobex was associated with a reduction in mortality in COVID-19 by over 22%, as reported in a retrospective study utilizing complete health data from the Czech national registry
Veselý et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2026.108519
https://c19early.org/vesely.html